Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 006317

Expand all

SULFONAMIDES DUPLEX (SULFADIAZINE; SULFAMERAZINE)
250MG/5ML;250MG/5ML
Marketing Status: Discontinued

Active Ingredient: SULFADIAZINE; SULFAMERAZINE
Proprietary Name: SULFONAMIDES DUPLEX
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: 250MG/5ML;250MG/5ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N006317
Product Number: 007
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ELI LILLY AND CO
Marketing Status:  Discontinued
Patent and Exclusivity Information

NEOTRIZINE (TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE))
167MG/5ML;167MG/5ML;167MG/5ML
Marketing Status: Discontinued

Active Ingredient: TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE)
Proprietary Name: NEOTRIZINE
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: 167MG/5ML;167MG/5ML;167MG/5ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N006317
Product Number: 012
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ELI LILLY AND CO
Marketing Status:  Discontinued
Patent and Exclusivity Information

NEOTRIZINE (TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE))
167MG;167MG;167MG
Marketing Status: Discontinued

Active Ingredient: TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE)
Proprietary Name: NEOTRIZINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 167MG;167MG;167MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N006317
Product Number: 011
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ELI LILLY AND CO
Marketing Status:  Discontinued
Patent and Exclusivity Information